降低固体生产的硫化加速动脉样硬化
Sarathi Mani1, Hongzhu Li, Ashley Untereiner
1Department of Biology, Lakehead University, Thunder Bay, ON, Canada.
Circulation
|May 25, 2013
概括
减少硫化 (H2S) 的产生加速动脉样硬化. 补充NaHS可以在缺乏cystathionine γ-lyase (CSE) 的小鼠中预防饮食诱导的动脉样硬化,强调CSE/H2S途径作为治疗标.
科学领域:
- 心血管生物学 心血管生物学
- 代谢性疾病研究研究
- 动脉样硬化病原体的产生
背景情况:
- 囊氨酸γ-酶 (CSE) 对于心血管系统内固有的硫化 (H2S) 生产至关重要.
- 在小鼠中,CSE缺乏导致H2S水平降低,血压升高和血管松功能受损.
- 改变内源H2S代谢在动脉样硬化中的直接作用尚不清楚.
研究的目的:
- 调查内源性H2S产量减少在动脉样硬化发展中的因果作用.
- 评估针对动脉样硬化中CSE/H2S通路的治疗潜力.
主要方法:
- 六周大的CSE基因淘汰和野生型小鼠在12周内被食控制或异质性饮食.
- 分析包括血脂质谱,同氨酸,血压,氧化应激,病变大小,细胞增殖和粘附分子表达.
- 用NAHS,N-乙半氨酸或ezetimibe治疗CSE淘汰的小鼠;还研究了双重淘汰 (CSE和apolipoprotein E).
主要成果:
- 接受异质性饮食的CSE绝杀性小鼠表现出早期脂肪链病变,高胆固醇和LDL,高血糖血,氧化应激增加和大动脉内脏增多.
- 在CSE淘汰赛小鼠中,NaHS治疗改善了饮食诱导的动脉样硬化,而N-乙半氨酸和ezetimibe则没有.
- 与单次淘汰相比,CSE和阿波利波蛋白E基因的联合淘汰会加剧动脉样硬化.
结论:
- 通过CSE途径合成的内源H2S通过减少内密增殖和粘附分子表达来防止动脉动脉损伤.
- 减少内源H2S的产生促进了血管重塑,加速了动脉样硬化的发展.
- CSE/H2S通路代表了预防动脉样硬化的重要治疗目标.
相关概念视频
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Sulfur Assimilation
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Microbes and the Sulfur Cycle
Sulfur is a vital element in Earth's biogeochemical systems. It transitions through various inorganic states, including sulfate (SO₄²⁻), elemental sulfur (S⁰), and sulfide (S²⁻). Abiotic and biological mechanisms across oxic and anoxic environments intricately mediate these transformations. Sulfate, the most oxidized form of sulfur, is predominantly stored in rocks, marine sediments, and oceanic waters, acting as a long-term reservoir in the global sulfur cycle.In oxic environments,...
